Page last updated: 2024-09-04

naproxen and Cholera Infantum

naproxen has been researched along with Cholera Infantum in 100 studies

Research

Studies (100)

Timeframe	Studies, this research(%)	All Research%
pre-1990	24 (24.00)	18.7374
1990's	16 (16.00)	18.2507
2000's	41 (41.00)	29.6817
2010's	16 (16.00)	24.3611
2020's	3 (3.00)	2.80

Authors

Authors	Studies
Blythin, DJ; Bober, LA; Chiu, PJ; Conn, DJ; Domalski, MS; Kaminski, JJ; Solomon, DM; Spitler, J; Verbiar, LL; Wong, SC	1
Casler, JJ; Collins, PW; Gregory, SA; Isakson, PC; Khanna, IK; Koboldt, CM; Koszyk, FJ; Masferrer, JL; Perkins, WE; Seibert, K; Veenhuizen, AW; Weier, RM; Xu, XD; Yu, Y; Zhang, YY	1
Charitos, C; Doulgkeris, C; Galanakis, D; Gavalas, A; Kourounakis, AP; Kourounakis, PN; Kravaritou, C; Rekka, EA; Tsiakitzis, KC	1
Aldhubiab, BE; Attimarad, M; Goyal, M; Gupta, GL; Kandeel, M; Kumar, M; Morsy, MA; Mujwar, S; Nagaraja, S; Nair, AB; Sharma, M; Shinu, P; Singh, P; Telsang, M; Venugopala, KN	1
Jastorff, J; Prevoo, M; Schöfl, R; van de Laar, MAFJ	1
Kang, CN; Kim, HJ; Kim, JH; Lee, S; Lee, WS; Moon, SH; Park, MS; Shin, SJ	1
Crossley, A; Moore, A; Ng, B; Phillips, L; Rainsford, KD; Sancak, Ö	1
Bao, W; Berger, MF; Borer, JS; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Menon, V; Nissen, SE; Solomon, DH; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND	1
Bao, W; Borer, JS; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Nissen, SE; Solomon, DH; Stevens, T; Vargo, J; Walker, C; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND	1
Abramson, S; Arber, N; Baigent, C; Baron, JA; Bhala, N; Bombardier, C; Cannon, C; Emberson, J; Farkouh, ME; FitzGerald, GA; Goss, P; Halls, H; Hawk, E; Hawkey, C; Hennekens, C; Hochberg, M; Holland, LE; Kearney, PM; Laine, L; Lanas, A; Lance, P; Laupacis, A; Merhi, A; Oates, J; Patrono, C; Schnitzer, TJ; Solomon, S; Tugwell, P; Wilson, K; Wittes, J	1
Angiolillo, DJ; Datto, C; Raines, S; Yeomans, ND	1
Tjwa, ET; van den Bemt, P; van Oijen, MG	1
Barbosa, AL; Carvalho, NS; Damasceno, SR; Leite, JR; Medeiros, JV; Nicolau, LA; Silva, DA; Silva, MM; Silva, RO; Sousa, FB	1
Bao, W; Beckerman, B; Berger, MF; Borer, JS; Gaffney, M; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Menon, V; Nissen, SE; Ruschitzka, F; Solomon, DH; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND	1
Aragão, KS; Carvalho, NS; Leite, JRSA; Lucetti, LT; Medeiros, JVR; Nicolau, LAD; Pacífico, DM; Souza, MHLP; Véras, LMC	1
Jackson, G	1
Bolla, M; Viappiani, S; Wallace, JL	1
Bart, B; Bell, M; Burnett, BP; Caldron, P; Ermolova, T; Kantemirova, R; Khokhlov, A; Kopenkin, S; Levy, RM; Mazurov, V; Pillai, L	1
Aletaha, D; Buchbinder, R; Landewé, RB; Radner, H; Ramiro, S; van der Heijde, D	1
Blackler, R; Bolla, M; Ongini, E; Syer, S; Wallace, JL	1
Bhadra, P; Essex, MN; Sands, GH	1
Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K	1
Barbosa, AL; Bezerra, TS; Carvalho, NS; Chaves, LS; Damasceno, SR; Freitas, AL; Medeiros, JV; Oliveira, CB; Santana, AP; Silva, RO; Soares, PM; Souza, MH	1
Jain, NK; Kulkarni, SK; Patil, CS; Singh, A	1
Bombardier, C; Brett, C; Davis, B; Hawkey, CJ; Laine, L; Reicin, A; Shapiro, D	1
Bombardier, C; Burgos-Vargas, R; Connors, LG; Hawkey, CJ; Laine, L; Reicin, A; Schnitzer, TJ; Yu, Q	1
Goldstein, JL; Kent, JD; Kivitz, AJ; Palmer, RC; Recker, DP; Verburg, KM	1
Branson, J; Ford, M; Kellett, N; Mair, S; Milosavljev, S; Rordorf, C; Scott, G	1
Schiller, LR	1
Akyürek, C; Celik, C; Celik, JB; Reisli, R; Sarkilar, G; Tuncer, S	1
Dixon, ME; Geba, GP; Johansson, G; Lisse, JR; Mollen, AJ; Perlman, M; Polis, AB; Schechtman, J; Shoemaker, JR; Skalky, CS	1
Atherton, CT; Bebb, JR; Bjarnason, IT; Fagerholm, U; Hawkey, CJ; Jones, JI; Jonzon, B; Karlsson, P; Skelly, MM	1
Choi, HK; Kuntz, KM; Seeger, JD	1
Hanauer, LB	1
Jenkinson, ML	1
Rusche, JM	1
Lanes, S; Singh, G; Triadafilopoulos, G	1
Fitzgerald, GA	1
Cryer, B; Cung, A; Kazi, S; Kelly, KC; Little, BB; Roberts, KW; Sarosi, GA; Smith, HJ; Weideman, RA	1
Chiou, CF; Ofman, JJ; Spiegel, BM	1
Braunstein, N; Polis, A	1
Waxman, HA	1
Frazier, KC	1
Whittle, BJ	1
Brensinger, C; Farrar, JT; Kimmel, SE; Lewis, JD; Localio, AR; McGibney, K; Metz, DC; Nessel, L; Strom, BL	1
Hazleman, BL; Ostor, AJ	1
Curfman, GD; Drazen, JM; Morrissey, S	1
Bombardier, C; Burgos-Vargas, R; Davis, B; Day, R; Ferraz, MB; Hawkey, CJ; Hochberg, MC; Kvien, TK; Laine, L; Schnitzer, TJ; Weaver, A	1
Reicin, A; Shapiro, D	1
Smith, R	1
Biskupiak, JE; Brixner, DI; Howard, K; Oderda, GM	1
Brookhart, MA; Rassen, J; Schneeweiss, S; Solomon, DH; Wang, PS	1
Bergman, G; Curtis, SP; Ko, AT; Malmstrom, K; Mehta, A; Reginster, JY; Reicin, AS	1
Einecke, D	1
Ji, H; Peng, SX; Zhang, YH	1
Hawkey, CJ; Krammer, G; Murphy, V; Rebuli, R; Richard, D; Stricker, K; Weinstein, WM	1
Felder, M	1
Burry, HC; Siebers, R	1
Casini-Raggi, V; Cominelli, F; Laine, L; Marin-Sorensen, M; Sloane, R; Weinstein, WM	1
Geis, GS	1
Bruyn, GA; Geis, GS; Melo Gomes, JA; Roth, SH; Woods, EM; Zeeh, J	1
Aabakken, L; Axelsson, CK; Szecsi, PB	1
DeLapp, RE; Eversmeyer, W; Jensen, CP; Poland, M	1
Dobson, A; Henry, D; Turner, C	1
Barceló, P; Bevis, PJ; Bluhmki, E; Distel, M; Le Loët, X; Schattenkirchner, M; Wojtulewski, JA	1
Butler, J; Devane, JG; Mulligan, S	1
Lisse, JR	1
Bjarnason, I; Hayllar, J; Macpherson, A; Rotman, H; Schupp, J	1
Baethge, B; Botstein, GR; Caldwell, J; Dietz, F; Ettlinger, R; Furst, DE; Golden, HE; Lindsley, H; McLaughlin, GE; Moreland, LW; Roberts, WN; Rooney, TW; Rothschild, B; Sack, M; Sebba, AI; Weisman, M; Welch, KE; Yocum, D	1
Bombardier, C; Burgos-Vargas, R; Davis, B; Day, R; Ferraz, MB; Hawkey, CJ; Hochberg, MC; Kvien, TK; Laine, L; Reicin, A; Schnitzer, TJ; Shapiro, D	1
Barry, M; Bjarnason, I; Fitzgerald, DJ; Gudjonsson, H; Kay, E; Murray, FE; Oddsson, E; Price, AB; Shah, AA; Sigthorsson, G; Thjodleifsson, B	1
Adelman, A	1
Lussier, A; Melton, JW; Multz, C; Neustadt, D; Ward, JR	1
Kajanoja, P; Vesanto, T	1
Ciccolunghi, SN; Reddrop, R; Schubiger, BI	1
Balme, HW; Franklin, S; Huskisson, EC; Scott, J; Woolf, DL	1
Boost, G	1
Aabakken, L	1
Calhoun, W; Carlson, RP; Copenhaver, TW; Datko, LJ; Gilman, SC	1
de Pouvourville, G	1
Brørs, O; Kvien, TK; Nordby, J; Rognstad, S; Staff, PH	1
Doucette, M; Ekholm, B; Goldlust, B; Lanza, F; Rack, MF; Wilson, R	1
Allen, B; Edwards, IR	1
Giercksky, KE; Huseby, G; Rugstad, HE	1
Aabakken, L; Dybdahl, JH; Eidsaunet, W; Haaland, A; Larsen, S; Osnes, M	1
Paulus, HE; Schlegel, SI	1
Cuttica, R; Garay, SM; García-Morteo, O; Maldonado-Cocco, JA	1
Kolodny, AL	1
Gabor, I; Lereim, P	1
Heere, LP	1
Roth, SH	1
Giercksky, KE; Herland, OB; Holme, I; Husby, G; Rugstad, HE	1
Altman, R	1
Catalano, MA	1
Husby, G	1
Geczy, M; Peltier, L; Wolbach, R	1
Gordin, A; Nuutila, J; Sotka, S	1

Reviews

11 review(s) available for naproxen and Cholera Infantum

Article	Year
Predictive value of gastrointestinal symptoms and patient risk factors for NSAID-associated gastrointestinal ulcers defined by endoscopy? Insights from a pooled analysis of two naproxen clinical trials. PloS one, 2023, Volume: 18, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Endoscopy; Gastrointestinal Diseases; Humans; Naproxen; Pain; Randomized Controlled Trials as Topic; Risk Factors; Ulcer	2023
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England), 2013, Aug-31, Volume: 382, Issue:9894 Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Vessels; Coronary Disease; Cyclooxygenase 2 Inhibitors; Diclofenac; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Ibuprofen; Myocardial Infarction; Naproxen; Stroke; Vascular Diseases	2013
[Cardiovascular and gastrointestinal safety of NSAIDs]. Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Gastrointestinal Diseases; Humans; Naproxen; Proton Pump Inhibitors	2014
Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity. The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Female; Gastrointestinal Diseases; Humans; Liver Diseases; Male; Middle Aged; Naproxen; Pain; Pain Management	2012
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective. Spine, 2013, May-15, Volume: 38, Issue:11 Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes	2013
Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis and rheumatism, 2005, Apr-15, Volume: 53, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cost-Benefit Analysis; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Lactones; Lansoprazole; Naproxen; Omeprazole; Proton Pump Inhibitors; Pyrazoles; Rheumatology; Sulfonamides; Sulfones	2005
Nitric oxide-modulating agents for gastrointestinal disorders. Expert opinion on investigational drugs, 2005, Volume: 14, Issue:11 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Enteritis; Esophagus; Fissure in Ano; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Naproxen; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Peroxynitrous Acid	2005
The murky waters of the coxibs: a review of the current state of play. Inflammopharmacology, 2005, Volume: 13, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endothelium, Vascular; Gastrointestinal Diseases; Humans; Naproxen; Risk Assessment	2005
[A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs]. Yao xue xue bao = Acta pharmaceutica Sinica, 2007, Volume: 42, Issue:4 Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Cyclooxygenase Inhibitors; Flurbiprofen; Gastrointestinal Diseases; Humans; Ibuprofen; Naproxen; Nitrates; Nitric Oxide Donors	2007
NSAID-associated gastrointestinal damage: methodological considerations and a review of the experience with enteric coated naproxen. European journal of rheumatology and inflammation, 1992, Volume: 12, Issue:2 Topics: Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Humans; Naproxen; Tablets, Enteric-Coated	1992
Non-steroidal and analgesic therapy in the elderly. Clinics in rheumatic diseases, 1986, Volume: 12, Issue:1 Topics: Acetaminophen; Aged; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents; Apazone; Aspirin; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Diclofenac; Drug Hypersensitivity; Gastrointestinal Diseases; Hematologic Diseases; Humans; Ibuprofen; Indomethacin; Ketoprofen; Kidney Diseases; Kinetics; Naproxen; Phenylbutazone; Piroxicam; Salicylates; Thiazines	1986

Trials

46 trial(s) available for naproxen and Cholera Infantum

Article	Year
A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis. PloS one, 2020, Volume: 15, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Double-Blind Method; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Male; Naproxen; Osteoarthritis; Pain; Prospective Studies; Surveys and Questionnaires	2020
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial. Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Celecoxib; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Kidney Diseases; Male; Middle Aged; Naproxen; Osteoarthritis; Risk Factors; Treatment Outcome	2018
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:11 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Celecoxib; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Osteoarthritis; Treatment Outcome	2018
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies. Journal of thrombosis and thrombolysis, 2014, Volume: 38, Issue:1 Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Delayed-Action Preparations; Double-Blind Method; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen; Osteoarthritis	2014
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. The New England journal of medicine, 2016, 12-29, Volume: 375, Issue:26 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Intention to Treat Analysis; Kidney Diseases; Male; Middle Aged; Naproxen; Risk	2016
Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Advances in therapy, 2010, Volume: 27, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Catechin; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Lipoxygenase Inhibitors; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Respiratory Tract Diseases	2010
Efficacy and tolerability of celecoxib versus naproxen in patients with osteoarthritis of the knee: a randomized, double-blind, double-dummy trial. The Journal of international medical research, 2012, Volume: 40, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Pyrazoles; Sulfonamides; Treatment Outcome	2012
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology, 2002, Volume: 123, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Age Distribution; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Double-Blind Method; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lactones; Middle Aged; Multivariate Analysis; Naproxen; Risk Factors; Sulfones; Treatment Outcome	2002
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology, 2003, Volume: 124, Issue:2 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Incidence; Isoenzymes; Lactones; Male; Membrane Proteins; Middle Aged; Naproxen; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Sulfones	2003
A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects. Alimentary pharmacology & therapeutics, 2003, Jul-01, Volume: 18, Issue:1 Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Isoxazoles; Naproxen; Osteoarthritis; Pain; Risk Factors; Sulfonamides	2003
Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects. Alimentary pharmacology & therapeutics, 2003, Sep-01, Volume: 18, Issue:5 Topics: Adolescent; Adult; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Isoenzymes; Male; Membrane Proteins; Middle Aged; Naproxen; Organic Chemicals; Pilot Projects; Prostaglandin-Endoperoxide Synthases; Thromboxanes	2003
A comparative study of the effect of rofecoxib (a COX 2 inhibitor) and naproxen sodium on analgesic requirements after abdominal hysterectomy. Archives of gynecology and obstetrics, 2003, Volume: 268, Issue:4 Topics: Adult; Analgesia; Cyclooxygenase Inhibitors; Dyspepsia; Female; Gastrointestinal Diseases; Heartburn; Humans; Hysterectomy; Lactones; Middle Aged; Morphine; Naproxen; Placebos; Postoperative Nausea and Vomiting; Premedication; Sulfones	2003
Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Annals of internal medicine, 2003, Oct-07, Volume: 139, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Hypertension; Lactones; Male; Middle Aged; Naproxen; Osteoarthritis; Prospective Studies; Sulfones	2003
Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans. Gut, 2003, Volume: 52, Issue:11 Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cell Membrane Permeability; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Duodenal Diseases; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naphthalenes; Naproxen; Nitric Oxide Donors; Stomach Diseases	2003
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. The American journal of medicine, 2004, Jul-15, Volume: 117, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular System; Diclofenac; Dose-Response Relationship, Drug; Europe; Female; Gastrointestinal Diseases; Humans; Male; Meloxicam; Middle Aged; Naproxen; North America; Piroxicam; Risk Factors; Severity of Illness Index; Thiazines; Thiazoles; Thromboembolism; Time Factors; Treatment Failure; Upper Gastrointestinal Tract	2004
Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Annals of the rheumatic diseases, 2007, Volume: 66, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen; Osteoarthritis; Pain Measurement; Pyridines; Sulfones; Time Factors; Treatment Outcome	2007
Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment--findings from the Therapeutic Arthritis Research and Gastrointestinal Even Alimentary pharmacology & therapeutics, 2008, Volume: 27, Issue:9 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Statistics as Topic	2008
A comparison of flurbiprofen with naproxen in ankylosing spondylitis. The New Zealand medical journal, 1980, Oct-22, Volume: 92, Issue:670 Topics: Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; Gastrointestinal Diseases; Humans; Male; Naproxen; Propionates; Spondylitis, Ankylosing	1980
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Etodolac; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Middle Aged; Naproxen; Prostaglandins; Stomach Ulcer	1995
Efficacy and upper GI safety of diclofenac/misoprostol, piroxicam and naproxen in patients with osteoarthritis. Drugs, 1993, Volume: 45 Suppl 1 Topics: Diclofenac; Double-Blind Method; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Male; Misoprostol; Naproxen; Osteoarthritis; Piroxicam; Safety	1993
Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis. Annals of the rheumatic diseases, 1993, Volume: 52, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Diclofenac; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Misoprostol; Naproxen; Osteoarthritis; Peptic Ulcer; Piroxicam	1993
Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteers. Scandinavian journal of gastroenterology, 1993, Volume: 28, Issue:6 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Double-Blind Method; Duodenum; Gastric Mucosa; Gastrointestinal Diseases; Humans; Indenes; Intestinal Mucosa; Male; Naproxen; Pepsinogens; Piroxicam	1993
Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. The American journal of medicine, 1993, Aug-09, Volume: 95, Issue:2A Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Butanones; Diclofenac; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Male; Middle Aged; Nabumetone; Naproxen; Osteoarthritis; Piroxicam	1993
A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis. British journal of rheumatology, 1996, Volume: 35 Suppl 1 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Double-Blind Method; Drug Tolerance; Gastrointestinal Diseases; Humans; Meloxicam; Middle Aged; Naproxen; Thiazines; Thiazoles; Time Factors; Treatment Outcome	1996
Clinical efficacy and safety of Naprelan versus Naprosyn in the treatment of rheumatoid arthritis. American journal of orthopedics (Belle Mead, N.J.), 1996, Volume: 25, Issue:9 Suppl Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen; Safety	1996
A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen. Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:2 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Duodenum; Endoscopy, Gastrointestinal; Female; Gastrointestinal Diseases; Humans; Indans; Intestinal Mucosa; Isoenzymes; Male; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Stomach	1997
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Arthritis and rheumatism, 1999, Volume: 42, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Double-Blind Method; Eye Diseases; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Male; Middle Aged; Naproxen; Severity of Illness Index; Time Factors; Treatment Outcome	1999
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. The New England journal of medicine, 2000, 11-23, Volume: 343, Issue:21 Topics: Adult; Arthritis, Rheumatoid; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Duodenal Obstruction; Female; Gastric Outlet Obstruction; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Isoenzymes; Lactones; Male; Membrane Proteins; Middle Aged; Naproxen; Peptic Ulcer; Proportional Hazards Models; Prostaglandin-Endoperoxide Synthases; Sulfones	2000
Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut, 2001, Volume: 48, Issue:3 Topics: Adolescent; Adult; Aged; Biomarkers; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Gastric Mucosa; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Male; Middle Aged; Naproxen; Permeability; Platelet Aggregation; Prostaglandins E; Sulfonamides; Thromboxane B2	2001
Naproxen vs. aspirin in osteoarthritis of the hip and knee. The Journal of rheumatology, 1978,Fall, Volume: 5, Issue:3 Topics: Adult; Aged; Aspirin; Central Nervous System Diseases; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen; Osteoarthritis	1978
Naproxen and indomethacin in the treatment of primary dysmenorrhea. Acta obstetricia et gynecologica Scandinavica. Supplement, 1979, Volume: 87 Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Dysmenorrhea; Female; Gastrointestinal Diseases; Humans; Indomethacin; Naproxen	1979
Four new anti-inflammatory drugs: responses and variations. British medical journal, 1976, May-01, Volume: 1, Issue:6017 Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Fenoprofen; Gastrointestinal Diseases; Humans; Ibuprofen; Ketoprofen; Naproxen; Pain	1976
[Long-term therapy of progressive chronic polyarthritis with naproxen]. Arzneimittel-Forschung, 1975, Volume: 25, Issue:2A Topics: Arthritis, Rheumatoid; Chronic Disease; Clinical Trials as Topic; Follow-Up Studies; Gastrointestinal Diseases; Humans; Long-Term Care; Male; Middle Aged; Naphthaleneacetic Acids; Naproxen; Placebos; Time Factors	1975
An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen. The Journal of rheumatology, 1989, Volume: 16, Issue:12 Topics: Alanine Transaminase; Aspartate Aminotransferases; Duodenal Diseases; Endoscopy; Gastrointestinal Diseases; Humans; L-Lactate Dehydrogenase; Liver; Naproxen; Salicylates	1989
A safety profile of controlled release naproxen tablets. The New Zealand medical journal, 1989, Jun-28, Volume: 102, Issue:870 Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Drug Evaluation; Follow-Up Studies; Gastrointestinal Diseases; Humans; Middle Aged; Naproxen; Patient Compliance; Random Allocation; Tablets; Time Factors	1989
Epidemiology of NSAID-related gastrointestinal side effects. Scandinavian journal of gastroenterology. Supplement, 1989, Volume: 163 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Gastric Mucosa; Gastrointestinal Diseases; Humans; Male; Middle Aged; Multicenter Studies as Topic; Naproxen; Osteoarthritis; Piroxicam	1989
Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers. Scandinavian journal of gastroenterology, 1989, Volume: 24, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Double-Blind Method; Duodenoscopy; Gastric Mucosa; Gastrointestinal Diseases; Gastroscopy; Humans; Indenes; Intestinal Mucosa; Male; Naproxen; Occult Blood; Random Allocation	1989
Piroxicam in juvenile rheumatoid arthritis. European journal of rheumatology and inflammation, 1987, Volume: 8, Issue:1 Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Male; Naproxen; Piroxicam; Transaminases	1987
Two double blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritis. The Journal of rheumatology, 1988, Volume: 15, Issue:8 Topics: Adult; Aged; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Middle Aged; Naproxen; Nervous System Diseases; Severity of Illness Index	1988
Piroxicam and naproxen in acute sports injuries. The American journal of medicine, 1988, May-20, Volume: 84, Issue:5A Topics: Acute Disease; Athletic Injuries; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Naproxen; Pain; Pain Measurement; Piroxicam; Self Concept	1988
Piroxicam in acute musculoskeletal disorders and sport injuries. European journal of rheumatology and inflammation, 1987, Volume: 8, Issue:1 Topics: Acute Disease; Adult; Athletic Injuries; Central Nervous System Diseases; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Humans; Indomethacin; Male; Muscular Diseases; Naproxen; Piroxicam	1987
A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis. Clinical rheumatology, 1986, Volume: 5, Issue:1 Topics: Aged; Cardiovascular Diseases; Central Nervous System Diseases; Clinical Trials as Topic; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen; Osteoarthritis; Pain; Piroxicam; Thiazines	1986
International experiences with diclofenac in osteoarthritis. The American journal of medicine, 1986, Apr-28, Volume: 80, Issue:4B Topics: Aspirin; Clinical Trials as Topic; Diclofenac; Diflunisal; Double-Blind Method; Gastrointestinal Diseases; Humans; Ibuprofen; Indomethacin; Naproxen; Osteoarthritis; Random Allocation; Sulindac	1986
Worldwide safety experience with diclofenac. The American journal of medicine, 1986, Apr-28, Volume: 80, Issue:4B Topics: Adult; Aged; Aspirin; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Female; Gastrointestinal Diseases; Gastroscopy; Humans; Ibuprofen; Kidney Diseases; Middle Aged; Naproxen; Occult Blood; Piroxicam; Thiazines	1986
The Norwegian multicenter study. The American journal of medicine, 1986, Nov-28, Volume: 81, Issue:5B Topics: Adult; Age Factors; Aged; Aged, 80 and over; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Naproxen; Norway; Osteoarthritis; Peptic Ulcer; Piroxicam; Random Allocation; Sex Factors	1986
Comparison of a slow-release indomethacin tablet and naproxen in osteoarthrosis. Current medical research and opinion, 1985, Volume: 9, Issue:7 Topics: Adult; Aged; Central Nervous System Diseases; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Gastrointestinal Diseases; Hip Joint; Humans; Indomethacin; Knee Joint; Male; Middle Aged; Movement; Naproxen; Osteoarthritis; Pain; Random Allocation; Tablets	1985

Other Studies

43 other study(ies) available for naproxen and Cholera Infantum

Article	Year
Antiinflammatory activity of substituted 6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-triones. Atypical nonsteroidal antiinflammatory agents. Journal of medicinal chemistry, 1986, Volume: 29, Issue:6 Topics: Animals; Anti-Inflammatory Agents; Arthritis; Biological Availability; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Male; Purines; Pyrimidines; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Ulcer	1986
1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents. Journal of medicinal chemistry, 1997, May-23, Volume: 40, Issue:11 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Edema; Gastrointestinal Diseases; Humans; Imidazoles; Isoenzymes; Membrane Proteins; Mice; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Rats; Structure-Activity Relationship; Sulfonamides; Sulfones	1997
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity. Bioorganic & medicinal chemistry letters, 2004, Jul-16, Volume: 14, Issue:14 Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cholesterol; Cysteine; Drug Evaluation; Gastrointestinal Diseases; Lipoproteins, LDL; Mice; Rats; Triglycerides	2004
Computational Design, Synthesis, and Pharmacological Evaluation of Naproxen-Guaiacol Chimera for Gastro-Sparing Anti-Inflammatory Response by Selective COX2 Inhibition. Molecules (Basel, Switzerland), 2022, Oct-14, Volume: 27, Issue:20 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonate 15-Lipoxygenase; Cyclooxygenase 2; Gastrointestinal Diseases; Guaiacol; Humans; Naproxen; Oxygen	2022
Use of multicriteria decision analysis for assessing the benefit and risk of over-the-counter analgesics. The Journal of pharmacy and pharmacology, 2017, Volume: 69, Issue:10 Topics: Analgesics; Aspirin; Decision Support Techniques; Gastrointestinal Diseases; Humans; Ibuprofen; Naproxen; Nonprescription Drugs; Pain; Risk Assessment	2017
Gastroprotective properties of cashew gum, a complex heteropolysaccharide of Anacardium occidentale, in naproxen-induced gastrointestinal damage in rats. Drug development research, 2015, Volume: 76, Issue:3 Topics: Anacardium; Animals; Gastrointestinal Diseases; Male; Naproxen; Plant Extracts; Plant Gums; Polysaccharides; Rats; Rats, Wistar	2015
Epiisopiloturine hydrochloride, an imidazole alkaloid isolated from Pilocarpus microphyllus leaves, protects against naproxen-induced gastrointestinal damage in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 87 Topics: 4-Butyrolactone; Alkaloids; Animals; Dose-Response Relationship, Drug; Gastric Mucosa; Gastrointestinal Diseases; Imidazoles; Intestinal Mucosa; Male; Naproxen; Pilocarpus; Plant Extracts; Plant Leaves; Protective Agents; Rats; Rats, Wistar	2017
Seeds of doubt--ADVANTAGE no one. International journal of clinical practice, 2008, Volume: 62, Issue:11 Topics: Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Drug Industry; Gastrointestinal Diseases; Humans; Interprofessional Relations; Lactones; Naproxen; Sulfones	2008
Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis. Trends in pharmacological sciences, 2009, Volume: 30, Issue:3 Topics: Animals; Blood Pressure; Cardiovascular System; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Humans; Naproxen; Nitric Oxide Donors; Osteoarthritis	2009
Naproxen/esomeprazole (Vimovo). The Medical letter on drugs and therapeutics, 2010, Sep-20, Volume: 52, Issue:1347 Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Combinations; Esomeprazole; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Naproxen; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome	2010
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence. PloS one, 2012, Volume: 7, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Hypertension; Male; Naproxen; Nitrates; Obesity; Omeprazole; Pyrazoles; Rats; Rats, Inbred SHR; Rats, Wistar; Rats, Zucker; Sulfonamides	2012
A sulfated-polysaccharide fraction from seaweed Gracilaria birdiae prevents naproxen-induced gastrointestinal damage in rats. Marine drugs, 2012, Volume: 10, Issue:12 Topics: Animals; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Glutathione; Gracilaria; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Naproxen; Peroxidase; Polysaccharides; Rats; Rats, Wistar	2012
Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behavioural brain research, 2002, Jul-18, Volume: 133, Issue:2 Topics: Aging; Animals; Anxiety; Avoidance Learning; Cognition Disorders; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Gastrointestinal Diseases; Isoenzymes; Lactones; Lipopolysaccharides; Male; Membrane Proteins; Mice; Motor Activity; Muscarinic Antagonists; Naproxen; Postural Balance; Prostaglandin-Endoperoxide Synthases; Scopolamine; Sulfonamides; Sulfones	2002
Lower gastrointestinal complications of nonsteroidal anti-inflammatory drugs. Current gastroenterology reports, 2003, Volume: 5, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Humans; Lactones; Naproxen; Sulfones	2003
Summaries for patients. Gastrointestinal side effects of rofecoxib and naproxen. Annals of internal medicine, 2003, Oct-07, Volume: 139, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Hypertension; Lactones; Male; Middle Aged; Naproxen; Osteoarthritis; Prospective Studies; Sulfones	2003
Effects of rofecoxib and naproxen on life expectancy among patients with rheumatoid arthritis: a decision analysis. The American journal of medicine, 2004, May-01, Volume: 116, Issue:9 Topics: Aged; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Decision Support Techniques; Female; Gastrointestinal Diseases; Humans; Lactones; Life Expectancy; Male; Middle Aged; Myocardial Infarction; Naproxen; Quality of Life; Sulfones; Time Factors	2004
Tolerability of rofecoxib versus naproxen. Annals of internal medicine, 2004, Jun-15, Volume: 140, Issue:12 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Industry; Gastrointestinal Diseases; Humans; Lactones; Naproxen; Osteoarthritis; Research; Sulfones	2004
Tolerability of rofecoxib versus naproxen. Annals of internal medicine, 2004, Jun-15, Volume: 140, Issue:12 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Data Interpretation, Statistical; Gastrointestinal Diseases; Humans; Lactones; Naproxen; Osteoarthritis; Sulfones	2004
Tolerability of rofecoxib versus naproxen. Annals of internal medicine, 2004, Jun-15, Volume: 140, Issue:12 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Data Interpretation, Statistical; Gastrointestinal Diseases; Humans; Lactones; Naproxen; Osteoarthritis; Sulfones	2004
Coxibs and cardiovascular disease. The New England journal of medicine, 2004, Oct-21, Volume: 351, Issue:17 Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Approval; Drug Industry; Epoprostenol; Gastrointestinal Diseases; Humans; Isoenzymes; Isoxazoles; Lactones; Membrane Proteins; Naproxen; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Risk; Sulfonamides; Sulfones; Thromboxane A2; United States; United States Food and Drug Administration	2004
Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis. Gastroenterology, 2004, Volume: 127, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Cyclooxygenase Inhibitors; Etodolac; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen	2004
Report of specific cardiovascular outcomes of the ADVANTAGE trial. Annals of internal medicine, 2005, Jul-19, Volume: 143, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Humans; Lactones; Naproxen; Osteoarthritis; Sulfones	2005
The lessons of Vioxx--drug safety and sales. The New England journal of medicine, 2005, Jun-23, Volume: 352, Issue:25 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase Inhibitors; Drug Evaluation; Drug Industry; Gastrointestinal Diseases; Humans; Lactones; Marketing; Myocardial Infarction; Naproxen; Scientific Misconduct; Sulfones; United States	2005
The lessons of Vioxx. The New England journal of medicine, 2005, Sep-29, Volume: 353, Issue:13 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Drug Industry; Gastrointestinal Diseases; Humans; Lactones; Marketing; Naproxen; Product Surveillance, Postmarketing; Sulfones; United States; United States Food and Drug Administration	2005
Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology, 2005, Volume: 129, Issue:6 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Nonprescription Drugs; Random Allocation; Risk Factors; Upper Gastrointestinal Tract	2005
Expression of concern reaffirmed. The New England journal of medicine, 2006, Mar-16, Volume: 354, Issue:11 Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Lactones; Myocardial Infarction; Naproxen; Research Design; Sulfones; Thromboembolism	2006
Response to expression of concern regarding VIGOR study. The New England journal of medicine, 2006, Mar-16, Volume: 354, Issue:11 Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Data Interpretation, Statistical; Gastrointestinal Diseases; Humans; Lactones; Myocardial Infarction; Naproxen; Sulfones	2006
Response to expression of concern regarding VIGOR study. The New England journal of medicine, 2006, Mar-16, Volume: 354, Issue:11 Topics: Arthritis, Rheumatoid; Data Interpretation, Statistical; Gastrointestinal Diseases; Humans; Lactones; Myocardial Infarction; Naproxen; Risk; Sulfones	2006
Lapses at the new England journal of medicine. Journal of the Royal Society of Medicine, 2006, Volume: 99, Issue:8 Topics: Boston; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Drug Industry; Gastrointestinal Diseases; Humans; Interprofessional Relations; Lactones; Myocardial Infarction; Naproxen; Periodicals as Topic; Randomized Controlled Trials as Topic; Sulfones	2006
Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs. Journal of pain & palliative care pharmacotherapy, 2006, Volume: 20, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Infant; Infant, Newborn; Insurance Claim Review; Male; Middle Aged; Naproxen; Odds Ratio; Retrospective Studies	2006
Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis and rheumatism, 2006, Volume: 54, Issue:11 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Lactones; Male; Multivariate Analysis; Myocardial Infarction; Naproxen; Pyrazoles; Rheumatic Diseases; Risk Assessment; Risk Factors; Sulfonamides; Sulfones	2006
[By what means does the rheumatic patient with gastrointestinal risks fare best?]. MMW Fortschritte der Medizin, 2007, Mar-08, Volume: 149, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Controlled Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Gastrointestinal Diseases; Germany; Humans; Naproxen; Osteoarthritis; Proton Pump Inhibitors; Pyridines; Rheumatic Diseases; Risk Factors; Sulfones; United States	2007
Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain. Prescrire international, 2007, Volume: 16, Issue:92 Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Gastrointestinal Diseases; Gout; Humans; Ibuprofen; Naproxen; Pain; Pyridines; Sulfones	2007
[Non-steroidal antirheumatics: side-effects and interactions]. Schweizerische medizinische Wochenschrift, 1982, Aug-28, Volume: 112, Issue:35 Topics: Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Drug Interactions; Gastrointestinal Diseases; Humans; Indomethacin; Naproxen; ortho-Aminobenzoates; Phenylbutazone; Prostaglandins; Rheumatic Diseases; Salicylates; Stomach Ulcer	1982
Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology, 1993, Volume: 105, Issue:4 Topics: Administration, Oral; Administration, Rectal; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Aspirin; Case-Control Studies; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Humans; Incidence; Ketoprofen; Male; Middle Aged; Naproxen; Peptic Ulcer; Piroxicam; Prospective Studies; Risk Factors; Sex Factors; Time Factors	1993
IPDAS: a novel technology brings new benefits when applied to naproxen sodium. American journal of orthopedics (Belle Mead, N.J.), 1996, Volume: 25, Issue:9 Suppl Topics: Adolescent; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Digestive System; Dogs; Drug Delivery Systems; Gastrointestinal Diseases; Humans; Macaca mulatta; Male; Naproxen; Swine; Swine, Miniature	1996
Is rofecoxib safer than naproxen? The Journal of family practice, 2001, Volume: 50, Issue:3 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Double-Blind Method; Gastrointestinal Diseases; Humans; Lactones; Naproxen; Randomized Controlled Trials as Topic; Sulfones	2001
Comparisons of tolerability findings in international clinical trials. Rheumatology and rehabilitation, 1979, Volume: Suppl 2 Topics: Arthritis, Rheumatoid; Aspirin; Cardiovascular System; Clinical Trials as Topic; Diclofenac; Drug Tolerance; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Tests; Humans; Ibuprofen; Indomethacin; International Cooperation; Naproxen; Phenylacetates; Time Factors	1979
Interaction studies of tilomisole, aspirin, and naproxen in acute and chronic inflammation with assessment of gastrointestinal irritancy in the rat. Agents and actions, 1992, Volume: 36, Issue:1-2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Aspirin; Benzimidazoles; Bone and Bones; Carrageenan; Connective Tissue; Drug Interactions; Edema; Gastrointestinal Diseases; Inflammation; Male; Naproxen; Rats; Rats, Sprague-Dawley	1992
The economic consequences of NSAID-induced gastropathy: the French context. Scandinavian journal of rheumatology. Supplement, 1992, Volume: 96 Topics: Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Cost of Illness; Diclofenac; Duodenal Ulcer; Economics, Hospital; Etodolac; France; Gastrointestinal Diseases; Humans; Ketoprofen; Naproxen; National Health Programs; Piroxicam; Rheumatic Diseases; Sulindac	1992
Improved cost-effectiveness ratio with a patient self-adjusted naproxen dosing regimen in osteoarthritis treatment. Scandinavian journal of rheumatology, 1991, Volume: 20, Issue:4 Topics: Aged; Cost-Benefit Analysis; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Naproxen; Osteoarthritis; Self Administration	1991
Naproxen: antirheumatic efficacy and safety in patients with pre-existing gastrointestinal disease. Seminars in arthritis and rheumatism, 1988, Volume: 17, Issue:3 Suppl 2 Topics: Arthritis, Rheumatoid; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen	1988
Naproxen tolerability in the elderly: a summary report. The Journal of rheumatology, 1987, Volume: 14, Issue:2 Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Humans; Naproxen; Osteoarthritis; Patient Dropouts; Retrospective Studies	1987